|
Volumn 287, Issue 5, 2002, Pages 641-642
|
Postmenopausal hormone therapy and quality of life: No cause for celebration
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE;
CARDIOVASCULAR RISK;
CLINICAL PRACTICE;
CLINICAL TRIAL;
DEPRESSION;
DRUG EFFICACY;
FATIGUE;
FLUSHING;
GALLBLADDER DISEASE;
HORMONE SUBSTITUTION;
HUMAN;
ISCHEMIC HEART DISEASE;
LETTER;
OSTEOPOROSIS;
OUTCOMES RESEARCH;
PATIENT EDUCATION;
PHYSICAL ACTIVITY;
POSTMENOPAUSE;
PRESCRIPTION;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RISK BENEFIT ANALYSIS;
SURVIVAL RATE;
SYMPTOMATOLOGY;
THROMBOEMBOLISM;
TREATMENT OUTCOME;
|
EID: 0037028776
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.287.5.641 Document Type: Letter |
Times cited : (11)
|
References (20)
|